Number and percentage of NK-cells are decreased in growth hormone-deficient adults. 1996

J P Span, and G F Pieters, and A G Smals, and P P Koopmans, and P W Kloppenborg
Department of Medicine, University Hospital Nijmegen, The Netherlands.

Snell-Bagg mice and Ames dwarf mice repeatedly show severe immunodeficiencies, affecting mostly the thymus- dependent lymphocyte system, probably caused by growth hormone deficiency. In growth hormone-deficient children contradictory data on the immune status have been reported. We investigated indices of cellular immunity in 22 adult patients with proven growth hormone deficiency in comparison to those in 100 health volunteers. Cellular immunity was assessed using total leukocyte count, percentage lymphocytes, and percentage and absolute numbers of CD3, CD4, CD8, CD19, and CD3-CD56+ (NK)-cells. Comparison revealed statistically significantly lower percentage and absolute number of NK-cells (P < 0.001). Except for a trend toward an increased CD4/CD8 ratio, no statistically significant differences for B- and T-lymphocytes could be observed. No correlation between the percentage and absolute number of NK-cells, on one hand, and the duration of growth hormone deficiency or prolactin level, on the other hand, could be demonstrated. In all these respects men did not differ from women. So, in growth hormone-deficient adults the percentage and absolute number of NK-cells are decreased.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008231 Lymphopenia Reduction in the number of lymphocytes. Lymphocytopenia,Lymphocytopenias,Lymphopenias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

J P Span, and G F Pieters, and A G Smals, and P P Koopmans, and P W Kloppenborg
January 1990, Neuroendocrinology,
J P Span, and G F Pieters, and A G Smals, and P P Koopmans, and P W Kloppenborg
September 1995, Metabolism: clinical and experimental,
J P Span, and G F Pieters, and A G Smals, and P P Koopmans, and P W Kloppenborg
July 2006, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society,
J P Span, and G F Pieters, and A G Smals, and P P Koopmans, and P W Kloppenborg
December 1996, Journal of clinical pharmacy and therapeutics,
J P Span, and G F Pieters, and A G Smals, and P P Koopmans, and P W Kloppenborg
June 1999, Australian and New Zealand journal of medicine,
J P Span, and G F Pieters, and A G Smals, and P P Koopmans, and P W Kloppenborg
November 1991, Acta endocrinologica,
J P Span, and G F Pieters, and A G Smals, and P P Koopmans, and P W Kloppenborg
January 1999, Clinical hemorheology and microcirculation,
J P Span, and G F Pieters, and A G Smals, and P P Koopmans, and P W Kloppenborg
May 1995, Drugs,
J P Span, and G F Pieters, and A G Smals, and P P Koopmans, and P W Kloppenborg
September 2008, European journal of clinical investigation,
J P Span, and G F Pieters, and A G Smals, and P P Koopmans, and P W Kloppenborg
May 1992, The American journal of clinical nutrition,
Copied contents to your clipboard!